MedPath

Comparison of toric Implantabe Contact Lens (ICL) with toric Implantable Phakic Contact lens (IPCL)

Not Applicable
Not yet recruiting
Conditions
Myopia,
Registration Number
CTRI/2019/05/019157
Lead Sponsor
Care group Sight Solution LLP
Brief Summary

This is a prospective, randomized study designed to compare two types of phakic lenses; the toric ICL and the toric IPCL. The study will involve 40 eyes with high myopia with regular corneal astigmatism more than 1.25 D. These will be randomly allocated in 2 groups based on computer generated random number table. Group 1 will include 20 eyes which will undergo toric ICL implantation while Group 2 will include 20 eyes which will include 20 eyes which will undergo toric IPCL implantation. Parameters which will be assessed include uncorrected and best corrected visual acuity, keratometric and refractive cylinder, endothelial cell count, intraocular pressure, higher order aberrations, lens rotation, contrast sensitivity and glare acuity. All these investigations will be performed at baseline, 1 week, 1 month, 3 months and at 6 months follow up visit.

**ii.**

x.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

40 eyes, with high myopia and regular corneal astigmatism more than 1.25 D.

Exclusion Criteria
  • a) Presence of other associated ocular co-morbidities such as glaucoma, uveitis, or any posterior segment pathology.
  • b) Patients with irregular corneal astigmatism due to corneal scarring or other corneal abnormalities c) Patient not willing to participate or follow up in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Postoperative emmetropiaBaseline, 1 week, 1 month, 3 months and at 6 months
2. Phakic lens stabilityBaseline, 1 week, 1 month, 3 months and at 6 months
Secondary Outcome Measures
NameTimeMethod
1. Post operative higher order aberrations2. Contrast sensitivity and glare acuity

Trial Locations

Locations (1)

Dr. R.P Centre

🇮🇳

South, DELHI, India

Dr. R.P Centre
🇮🇳South, DELHI, India
Namrata Sharma
Principal investigator
9810856988
namrata.sharma@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.